A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry

A metabonomics approach based on liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS) was utilized to obtain potential biomarkers of coronary heart disease (CHD) patients and investigate the ZHENG types differentiation in CHD patients. The plasma samples of 20 CHD patients...

Full description

Bibliographic Details
Main Authors: Linlin Zhao, Ling Wan, Xinjian Qiu, Ruomeng Li, Shimi Liu, Dongsheng Wang
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2014/385102
id doaj-328981972b2744349509e338001973c0
record_format Article
spelling doaj-328981972b2744349509e338001973c02020-11-25T00:50:25ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882014-01-01201410.1155/2014/385102385102A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass SpectrometryLinlin Zhao0Ling Wan1Xinjian Qiu2Ruomeng Li3Shimi Liu4Dongsheng Wang5Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central south University, Changsha 410008, ChinaIntegrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central south University, Changsha 410008, ChinaIntegrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central south University, Changsha 410008, ChinaIntegrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central south University, Changsha 410008, ChinaIntegrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central south University, Changsha 410008, ChinaIntegrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central south University, Changsha 410008, ChinaA metabonomics approach based on liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS) was utilized to obtain potential biomarkers of coronary heart disease (CHD) patients and investigate the ZHENG types differentiation in CHD patients. The plasma samples of 20 CHD patients with phlegm syndrome, 20 CHD patients with blood-stasis syndrome, and 16 healthy volunteers were collected in the study. 26 potential biomarkers were identified in the plasma of CHD patients and 19 differential metabolites contributed to the discrimination of phlegm syndrome and blood-stasis syndrome in CHD patients (VIP>1.5; P<0.05) which mainly involved purine metabolism, pyrimidine metabolism, amino acid metabolism, steroid biosynthesis, and arachidonic acid metabolism. This study demonstrated that metabonomics approach based on LC-MS was useful for studying pathologic changes of CHD patients and interpreting the differentiation of ZHENG types (phlegm and blood-stasis syndrome) in traditional Chinese medicine (TCM).http://dx.doi.org/10.1155/2014/385102
collection DOAJ
language English
format Article
sources DOAJ
author Linlin Zhao
Ling Wan
Xinjian Qiu
Ruomeng Li
Shimi Liu
Dongsheng Wang
spellingShingle Linlin Zhao
Ling Wan
Xinjian Qiu
Ruomeng Li
Shimi Liu
Dongsheng Wang
A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
Evidence-Based Complementary and Alternative Medicine
author_facet Linlin Zhao
Ling Wan
Xinjian Qiu
Ruomeng Li
Shimi Liu
Dongsheng Wang
author_sort Linlin Zhao
title A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
title_short A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
title_full A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
title_fullStr A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
title_full_unstemmed A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
title_sort metabonomics profiling study on phlegm syndrome and blood-stasis syndrome in coronary heart disease patients using liquid chromatography/quadrupole time-of-flight mass spectrometry
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2014-01-01
description A metabonomics approach based on liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS) was utilized to obtain potential biomarkers of coronary heart disease (CHD) patients and investigate the ZHENG types differentiation in CHD patients. The plasma samples of 20 CHD patients with phlegm syndrome, 20 CHD patients with blood-stasis syndrome, and 16 healthy volunteers were collected in the study. 26 potential biomarkers were identified in the plasma of CHD patients and 19 differential metabolites contributed to the discrimination of phlegm syndrome and blood-stasis syndrome in CHD patients (VIP>1.5; P<0.05) which mainly involved purine metabolism, pyrimidine metabolism, amino acid metabolism, steroid biosynthesis, and arachidonic acid metabolism. This study demonstrated that metabonomics approach based on LC-MS was useful for studying pathologic changes of CHD patients and interpreting the differentiation of ZHENG types (phlegm and blood-stasis syndrome) in traditional Chinese medicine (TCM).
url http://dx.doi.org/10.1155/2014/385102
work_keys_str_mv AT linlinzhao ametabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT lingwan ametabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT xinjianqiu ametabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT ruomengli ametabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT shimiliu ametabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT dongshengwang ametabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT linlinzhao metabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT lingwan metabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT xinjianqiu metabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT ruomengli metabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT shimiliu metabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
AT dongshengwang metabonomicsprofilingstudyonphlegmsyndromeandbloodstasissyndromeincoronaryheartdiseasepatientsusingliquidchromatographyquadrupoletimeofflightmassspectrometry
_version_ 1725248195853811712